Echinocandins: Clinical Trials

4 trials of Echinocandins, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting, 1 completed, 1 terminated. 2 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 32Not yet recruiting 1, Terminated 1
Phase 41Completed 1

Follow Echinocandins: new trials by email Literature Review of Echinocandins trials Research Report on Echinocandins

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Echinocandin Added to Standard Treatment for Severe Pneumocystis Pneumonia
Echinocandins, Placebo (0.9% Sodium chloride) infusion - Pneumocystis Jirovecii Pneumonia
Phase 3Not yet recruitingMcGill University Health Centre/Research Institute of the McGill University Health Centre4162027-04-012026-11-05
Liposomal Amphotericin B for Invasive Fungal Disease in Solid Organ Transplant Recipients
Liposomal Amphotericin B, Alternative Systemic Antifungal Therapy - Invasive Fungal Infection, Solid Organ Transplantation
Not yet recruitingSichuan Provincial People's Hospital1202026-07-012026-06-24
A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole
SCY-078, Fluconazole, Echinocandin - Candidiasis, Invasive, Candidemia
Phase 3TerminatedScynexis, Inc.682022-08-032026-08-10
Pharmacokinetic Study on Echinocandins for Patients With Septic Shock Following Secondary Peritonitis (EPI Study)
Echinocandins - Septic Shock, Peritonitis
Phase 4CompletedCentre Hospitalier Universitaire de Nīmes242017-01-282025-12-10

Conditions studied

Candidemia (1)  ·  Candidiasis, Invasive (1)  ·  Invasive Fungal Infections (1)  ·  Opportunistic Infections (1)  ·  Peritonitis (1)  ·  Pneumonia, Pneumocystis (1)  ·  Shock, Septic (1)

Sponsors

Centre Hospitalier Universitaire de Nīmes (1)  ·  McGill University Health Centre/Research Institute of the McGill University Health Centre (1)  ·  Scynexis, Inc. (1)  ·  Sichuan Provincial People's Hospital (1)

Countries

Canada (2)  ·  China (2)  ·  France (2)  ·  Australia (1)  ·  Belgium (1)  ·  Bulgaria (1)  ·  Germany (1)  ·  Greece (1)  ·  Israel (1)  ·  Italy (1)  ·  South Africa (1)  ·  South Korea (1)  ·  Spain (1)  ·  United States (1)

Top investigators

Claire Roger, MD (1)  ·  David Angulo, MD (1)  ·  Emily G. McDonald, MD MSc (1)  ·  Lingai Pan, MD (1)  ·  Todd C. Lee, MD MPH (1)

Results publications

PMID 33846133, PMID 34988242

NIH funding

2016 (1)